Hyperthermic Intrathoracic Chemotherapy (HITOC) after Cytoreductive Surgery for Pleural Malignancies—A Retrospective, Multicentre Study

Hyperthermic Intrathoracic Chemotherapy (HITOC) after Cytoreductive Surgery for Pleural Malignancies—A Retrospective, Multicentre Study

In the context of quality assurance, the objectives were to describe the surgical treatment and postoperative morbidity (particularly renal insufficiency). A retrospective, multicentre study of patients who underwent cytoreductive surgery (CRS) with cisplatin-based HITOC was performed. The study was...

Full description

Bibliographic Details
Main Authors: Michael Ried, Julia Kovács, Till Markowiak, Karolina Müller, Gunnar Huppertz, Michael Koller, Hauke Winter, Laura V. Klotz, Rudolf Hatz, Julia Zimmermann, Bernward Passlick, Severin Schmid, Mohamed Hassan, Martin E. Eichhorn, Hans-Stefan Hofmann
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
HITOC
hyperthermic intrathoracic chemotherapy
chemoperfusion
pleural malignancy
pleural mesothelioma
cytoreductive surgery
Online Access:https://www.mdpi.com/2072-6694/13/18/4580

Internet

https://www.mdpi.com/2072-6694/13/18/4580

Similar Items